Project Manager - Pharmacist Evidence Analyst & Strategist Resume Example

Twenty-two years of experience at Kaiser Permanente in Drug Information Services, of which fourteen years are in formulary management as a Pharmacist Evidence Analyst and Strategist providing strategic analysis and drug use management.

State of California Pharmacy License Number: 42577    Expiration Date: April 30, 2017

• Natalie Aboubechara, PharmD, BCPS, Janna Afanasjeva, PharmD, BCPS, Gary Besinque, PharmD, FCSHP, Faon M. Bridges, PharmD, BCPS, Tim Chiu, PharmD, BCPS, Jennifer M. Day, PharmD, Ken James, PharmD, Doris J. Kao, PharmD, BCPS, Christina Maeda, PharmD, FCSHP, Jiwon Shin, PharmD, Jane Takagi, PharmD, FCSHP, FASHP, Quynhlam V. Tran, PharmD, Anne Tran-Pugh, PharmD, FCSHP, Marcia M. Tsai Ding, PharmD, Monica A. Yoshinaga, PharmD, BCPS. New Drugs of 2014-2015, Part 1, CJHP.  2015;November/December;27(6) 171-187.

• Elizabeth Bentley, PharmD, BCPS, Gary Besinque, PharmD, FCSHP, Jennifer Chang, PharmD, MPH, Stephen Cheng, PharmD, Jonathan Goulding, PharmD, Natalie Iwamiya, PharmD, BCPS, Fatima Karim, PharmD, Zipporah Matsunaga, PharmD, Quynhlam Tran, PharmD, Anne Tran-Pugh, PharmD, FCSHP, Monica Yoshinaga, PharmD, BCPS. New Drugs 2013, CJHP.  2013;July/August; 25(4) 103-124.

• Gary Besinque PharmD, Patrick Shin PharmD, BCPS, Timothy Chiu PharmD, BCPS, Quynhlam Tran PharmD, Anne Tran-Pugh PharmD, Jonathan Goulding PharmD, Brian Yamada PharmD, BCPS, Doug Monroe RPh MS, Monica Yoshinaga PharmD, BCPS, Cathlene Richmond PharmD, BCPS. New Drugs 2011, CJHP.  2012;January/February; 24(1):10-28.

• Janet Shin PharmD, T. Craig Cheetham PharmD, MS, Linda Wong MD, Fang Niu MS, Elizabeth Kass MD, Monica A. Yoshinaga PharmD, Mike Sorel, Jeffrey S. McCombs PhD, Steve Sidney MD, MPH.  The Impact of the iPLEDGE Program on Isotretinoin Fetal Exposure.  J Am Acad Dermatol.  2011;Dec;65(6):1117-25. Epub 2011 May 11.

• Gary Besinque PharmD, Nina Escasa-Torres PharmD, Natalie Iwamiya PharmD, BCPS, Debbie Kubota PharmD, Zipporah Matsunaga PharmD,  Daniel Powers PharmD, MBA, BCPS, Quynhlam Tran PharmD, Anne Tran-Pugh PharmD, Monica Yoshinaga PharmD.  New Drugs 2009–2010 CJHP.  2010;Nov/Dec; (22) 6. 

• Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.  Association between exposure to topical tacrolimus or pimecrolimus and cancers.  Ann Pharmacother. 2009 Dec;43(12):1956-63. Epub 2009 Nov 10. Cheetham TC, Wagner RA, Chiu G, Day JM, Yoshinaga MA, Wong L.  A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study.  J Am Acad Dermatol. 2006 Sep;55(3):442-8. Epub 2006 Jul 13.

• Hurst AK, Yoshinaga MA, Mitani GH, Foo KA, Jelliffe RW, Harrison EC.  Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.  Antimicrob Agents Chemother. 1990 Jun;34(6):1165-71.

• California Society of Health System Pharmacists: Seminar Meeting. New Drugs - Gotta Catch em All Part 1 and Part 2 - October 2016.
  
• WebEx Presentation. Kaiser Permanente Drug Information Services -New & Pipeline Drugs – June 2016.
  
• WebEx Presentation. Kaiser Permanente Drug Information Services -New & Pipeline Drugs – November 2012.

• American College of Clinical Pharmacists
  
• California Society of Health System Pharmacists
  
• Board of Pharmacy Specialties